Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Cara Therapeutics (NASDAQ: CARA)

$16.53 USD -$0.56 (-3.28%)
Last Price $16.53
Net Change $-0.56 (-3.28%)
Bid $0
Ask Price $0
Open Price $17.12
Previous Close Price $17.09
High Price $17.21
Low Price $16.49
Number of Trades 7,018
Volume 1,980,000
Fifty Two Week High $20.9 (2017-03-29)
Fifty Two Week Low $4.35 (2016-06-27)
Average Daily Volume 2,132,975
Share Outstanding 31,750 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.81 (2017-03-09)
2nd Quarter Earnings $-0.42 (2016-11-03)
3nd Quarter Earnings $-0.48 (2016-08-04)
4th Quarter Earnings $-0.39 (2016-05-05)
PE Ratio $0
EPS Growth $-6.86
Recent Earnings $-0.81
Annual EPS $-1.71
Last Quarter EPS $
Market Capitalization $0.52B
Insider Shareholders % 0.077%
Annual Revenue $0B
No. Shares Outstanding 31,750
Inst. Shareholder % 43.56%
Annual Net Income $0B
TTM Net Profit Margin $100.47
1-Year Return 149.32%
3-Year Return 7.69%
5-Year Return 28.04%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -6.86%
Dividends per Share $
Stock Split Ratio
Beta 3.17
Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.